Beta Bionics Targets $130M-$135M Revenue by 2026, Expands Sales
Beta Bionics aims for $130 million to $135 million in revenue by 2026, supported by an expanded sales force and pharmacy channel.
8 related stories
Beta Bionics aims for $130 million to $135 million in revenue by 2026, supported by an expanded sales force and pharmacy channel.
Air Lease stock rose significantly after an investor trimmed a $6.9 million stake, even as the company reported a $1 billion profit year.
Santos plans to cut 10% of its workforce as its growth projects approach completion and the company's annual profit misses estimates.
PepsiCo has rebranded its Sunbites snack line, emphasizing its fibre content.
Freshworks stock has fallen 60% over the past year despite a 16% revenue jump, as one investor sold $7 million in shares.
The WNBA players' union has offered a new collective bargaining agreement proposal that slightly lowers the revenue share numbers.
Several articles analyze various stocks, offering investment advice, discussing potential for growth, and examining dividend yields across different sectors including technology, energy, and finance.
Cadence has surpassed its quarterly profit and revenue estimates, driven by strong demand linked to artificial intelligence technologies.